|
Volumn 20, Issue 5, 2010, Pages 451-452
|
Omalizumab in severe allergic asthma: Efficacy assessment by comparison of symptom score and peak expiratory flow values before and after therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUDESONIDE;
FORMOTEROL;
MONTELUKAST;
NEDOCROMIL SODIUM;
OMALIZUMAB;
ALLERGIC ASTHMA;
ARTICLE;
COMPARATIVE STUDY;
COUGHING;
DAILY LIFE ACTIVITY;
DRUG EFFICACY;
HUMAN;
OUTCOME ASSESSMENT;
PATIENT MONITORING;
PEAK EXPIRATORY FLOW;
POLLEN ALLERGY;
SCORING SYSTEM;
SLEEP;
SYMPTOMATOLOGY;
WHEEZING;
AGED;
ANTIBODIES, MONOCLONAL;
ASTHMA;
COUGH;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
PEAK EXPIRATORY FLOW RATE;
RECOVERY OF FUNCTION;
RESPIRATORY SOUNDS;
RETROSPECTIVE STUDIES;
|
EID: 78649347959
PISSN: 10189068
EISSN: 16980808
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (6)
|